VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
ABBV
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
ABBVAbbVie Inc.
$284.89$503.3B
Overview & Tools
OverviewChart Terminal ↗AnalysisVisualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksABBVQuarterly Financials

AbbVie Inc. (ABBV) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

AbbVie Inc. (ABBV) quarterly income statement — complete revenue, gross profit & net income history

Income StatementBalance SheetCash FlowRatios

ABBV Income Statement

Quarterly statement

ABBV Income Statement

AbbVie Inc. (ABBV) annual income statement — 16-year revenue, gross profit & net income history

AnnualQuarterly
MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21
Sales/Revenue16.99B15B16.62B15.78B15.42B13.34B15.1B14.46B14.46B12.31B14.3B13.93B13.87B12.22B15.12B14.81B14.58B13.54B14.89B14.34B
Revenue Growth %10.16%12.43%10.04%9.1%6.64%8.39%5.6%3.83%4.31%0.7%-5.42%-5.97%-4.92%-9.7%1.58%3.28%4.47%4.06%7.42%11.16%
Cost of Goods Sold4.29B4.22B4.55B5.3B4.35B4B4.4B4.21B4.2B4.09B5.7B6.49B4.24B3.99B4.17B5.02B4.17B4.05B4.32B4.39B
COGS % of Revenue25.26%28.12%27.39%33.62%28.18%29.99%29.11%29.13%29.06%33.26%39.89%46.56%30.58%32.61%27.58%33.9%28.59%29.93%29.02%30.61%
Gross Profit12.7B10.78B12.07B10.47B11.08B9.34B10.71B10.25B10.26B8.22B8.6B7.44B9.63B8.24B10.95B9.79B10.41B9.49B10.57B9.95B
Gross Margin %74.74%71.88%72.61%66.38%71.82%70.01%70.89%70.87%70.94%66.74%60.11%53.44%69.42%67.39%72.42%66.1%71.41%70.07%70.98%69.39%
Gross Profit Growth %14.64%15.45%12.7%2.19%7.96%13.69%24.53%37.7%6.6%-0.28%-21.5%-23.98%-7.57%-13.15%3.64%-1.63%10.35%7.83%15.17%26.74%
Operating Expenses6.27B6.05B6.26B8.57B6.18B5.61B12.2B6.42B6.26B5.42B5.4B5.16B5.11B5.47B5.45B5.19B7.12B4.77B5.49B5.65B
OpEx % of Revenue36.89%40.33%37.65%54.31%40.09%42.03%80.76%44.38%43.3%44.01%37.77%37.06%36.87%44.75%36.04%35.02%48.81%35.23%36.89%39.37%
Selling, General & Admin3.63B3.58B3.9B3.57B3.25B3.29B3.85B4.21B3.38B3.31B3.19B3.37B3.27B3.04B3.42B3.3B5.41B3.13B3.26B3.08B
SG&A % of Revenue21.38%23.85%23.44%22.62%21.09%24.68%25.53%29.08%23.35%26.93%22.33%24.21%23.57%24.86%22.6%22.31%37.11%23.1%21.9%21.5%
Research & Development2.34B2.47B2.58B2.32B2.13B2.07B6.77B2.13B1.95B1.94B2.21B1.72B1.73B2.29B2.03B1.65B1.88B1.64B2.23B2.06B
R&D % of Revenue13.8%16.48%15.52%14.7%13.82%15.49%44.86%14.73%13.47%15.75%15.45%12.37%12.5%18.75%13.44%11.17%12.88%12.13%14.99%14.38%
Other Operating Expenses1000K0-1000K1000K1000K1000K1000K1000K1000K1000K01000K1000K1000K-1000K1000K-1000K001000K
Operating Income6.43B4.73B5.81B1.9B4.89B3.73B-1.49B3.83B4B2.8B3.19B2.28B4.51B2.77B5.5B4.6B3.29B4.72B5.07B4.31B
Operating Margin %37.86%31.56%34.96%12.07%31.73%27.98%-9.87%26.49%27.64%22.73%22.34%16.38%32.55%22.64%36.39%31.08%22.59%34.84%34.09%30.02%
Operating Income Growth %31.43%26.81%489.87%-50.3%22.41%33.42%-146.64%67.95%-11.41%1.08%-41.93%-50.45%36.97%-41.32%8.44%6.9%-25.8%14.96%35.2%32.29%
EBITDA8.37B6.67B7.8B3.97B6.94B5.77B612M5.91B6.13B4.87B5.27B4.52B6.77B4.89B7.66B6.81B5.35B6.77B7.05B6.43B
EBITDA Margin %49.25%44.46%46.91%25.15%45.02%43.26%4.05%40.87%42.38%39.58%36.86%32.43%48.85%40.04%50.65%45.96%36.67%50.01%47.38%44.85%
EBITDA Growth %20.51%15.56%1173.86%-32.88%13.3%18.47%-88.39%30.87%-9.51%-0.47%-31.18%-33.67%26.67%-27.7%8.59%5.83%-19.48%7.15%21.23%15.97%
D&A (Non-Cash Add-back)1.94B1.94B1.99B2.06B2.05B2.04B2.1B2.08B2.13B2.07B2.08B2.23B2.26B2.13B2.16B2.21B2.05B2.05B1.98B2.13B
EBIT6.72B1.76B3.38B1.45B2.29B2.36B-1.57B2.8B2.87B2.42B1.78B2.51B3.16B1.03B3.53B4.96B1.74B5.48B4.85B4.28B
Net Interest Income-679M-645M-655M-667M-678M-627M-610M-591M-506M-453M-378M-398M-454M-454M-476M-497M-532M-539M-571M-585M
Interest Income67M72M59M72M62M73M92M129M220M207M186M157M98M99M90M63M24M9M9M11M
Interest Expense746M717M714M739M740M700M702M720M726M660M564M555M552M553M566M560M556M548M580M596M
Other Income/Expense-2.15B-3.69B-3.14B-1.19B-3.34B-2.07B-779M-1.75B-1.85B-1.04B-1.98B-328M-1.9B-2.29B-2.54B-203M-2.11B212M-803M-618M
Pretax Income4.28B1.04B2.67B714M1.55B1.66B-2.27B2.08B2.15B1.75B1.21B1.95B2.61B475M2.96B4.4B1.18B4.93B4.27B3.69B
Pretax Margin %25.18%6.93%16.05%4.53%10.08%12.45%-15.02%14.41%14.84%14.26%8.47%14.02%18.82%3.89%19.61%29.71%8.11%36.41%28.69%25.71%
Income Tax662M342M853M526M613M372M-2.25B520M773M383M388M172M583M234M493M448M255M436M226M508M
Effective Tax Rate %15.47%32.92%31.97%73.67%39.45%22.4%98.99%24.95%36.02%21.82%32.01%8.81%22.34%49.26%16.63%10.18%21.56%8.85%5.29%13.77%
Net Income3.61B699M1.82B186M938M1.29B-22M1.56B1.37B1.37B822M1.78B2.02B239M2.47B3.95B924M4.49B4.04B3.18B
Net Margin %21.27%4.66%10.93%1.18%6.08%9.64%-0.15%10.8%9.47%11.12%5.75%12.77%14.6%1.96%16.35%26.66%6.34%33.17%27.17%22.17%
Net Income Growth %285.18%-45.65%8354.55%-88.08%-31.53%-6.06%-102.68%-12.2%-32.31%472.8%-66.76%-54.98%119.05%-94.68%-38.85%24.22%20.63%26.37%11133.33%37.74%
Net Income (Continuing)3.62B697M1.81B188M941M1.29B-23M1.56B1.37B1.37B824M1.78B2.03B241M2.47B3.95B928M4.49B4.04B3.18B
Discontinued Operations00000000000000000000
Minority Interest47M44M42M43M45M42M39M39M43M40M37M35M32M29M33M33M35M31M28M27M
EPS (Diluted)2.040.391.020.100.530.72-0.020.880.770.770.461.001.140.131.392.220.512.532.261.78
EPS Growth %284.91%-45.83%5735.36%-88.72%-31.17%-6.49%-103.93%-12%-32.46%492.31%-66.91%-54.95%123.53%-94.86%-38.5%24.72%21.43%27.14%19900%37.98%
EPS (Basic)2.040.391.020.100.530.72-0.020.880.770.770.461.001.140.131.402.230.522.542.291.78
Diluted Shares Outstanding1.77B1.77B1.77B1.77B1.77B1.77B1.77B1.77B1.77B1.77B1.77B1.77B1.77B1.78B1.78B1.78B1.78B1.78B1.78B1.78B
Basic Shares Outstanding1.77B1.77B1.78B1.77B1.77B1.77B1.77B1.77B1.77B1.77B1.77B1.77B1.77B1.77B1.77B1.77B1.77B1.77B1.77B1.77B
Dividend Payout Ratio84.97%441.49%160.3%1565.05%310.23%227.45%-176.23%200.73%202.48%319.46%147.75%129.69%1113.39%101.33%63.41%271.32%56.26%57.22%72.82%